Table II.
Demographics of the included patients
| Study | Arterial hypertension | Diabetes mellitus | Dyslipidemia | COPD | CAD | Arrhythmia | CHF | Renal Disease | Other comorbidities |
|---|---|---|---|---|---|---|---|---|---|
| Veerasuri et al9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Kaur et al10 | 1/1 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Brugliera et al11 | 3/3 | 2/3 | 1/3 | 1/3 | 0 | 0 | 0 | 1/3 | Hypothyroidism (n = 1) |
| Hanif et al12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Hasan et al13 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Gubitosa et al14 | 1/1 | 1/1 | 1/1 | 0 | 0 | 0 | 0 | 1/1 | Smoking history |
| Anwar et al15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Singh et al16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Wang et al17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Goldman et al18 | 13/16 | 8/16 | 8/16 | NR | NR | NR | 4/16 | 0/16 | Smoking history (n = 8) PAD (n = 8) |
| Sánchez et al19 | 10/30 | 8/30 | 1/30 | NR | 4/30 | 3/30 | NR | 1/30 | Smoking history (n = 3) PAD (n = 4) |
| Galanis et al20 | 1/1 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | Dementia |
| Bozzani et al21 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Mietto et al22 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Obesity |
| Baccellieri et al23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Obesity |
| Shao et al24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Lupus anticoagulant positive |
| Etkin et al25 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Muhammad et al26 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Heald et al27 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | History of smoking |
| Bellosta et al28 | 11/20 | 3/20 | NR | 2/20 | 2/20 | 5/20 | NR | 4/20 | Previous VS (n = 4) Obesity (n = 4) |
| Kaur et al29 | 0 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Kahlberg et al30 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Schultz et al31 | 1/2 | 0 | 1/2 | 0 | 0 | 0 | 0 | 0 | Obesity (n = 1) |
| Vacirca et al32 | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Fan et al33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Perini et al34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | None |
| Kashi et al35 | 4/5 | 1/5 | NR | 1/5 | NR | 2/5 | NR | 1/5 | Smoking (n = 2) PAD (n = 2) |
| Baeza et al36 | 2/3 | 1/3 | 2/3 | 1/3 | 0 | 2/3 | 0 | 0 | Smoking (n = 2) Obesity (n = 1) PAD (n = 1) |
| Garg et al37 | 1/3 | 1/3 | 1/3 | NR | NR | 1/3 | NR | NR | NR |
| Thompson et al38 | 0 | 1/1 | 0 | 0 | 0 | 0 | 0 | 0 | Rheumatoid arthritis |
| Levolger et al39 | 0 | 1/2 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Wengerter et al40 | 1/3 | 2/3 | 1/3 | 0 | 0 | 0 | 0 | 0 | Smoking (n = 1) |
| Chowdhury et al41 | 1/1 | 0 | 1/1 | 0 | 1/1 | 0 | 0 | 0 | Dementia |
| Liu et al42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Lung cancer |
CAD, Coronary artery disease; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; NR, not reported; PAD, peripheral artery disease; VS, vascular surgery.